By James T. Mulder / The Post-Standard A revolutionary new study of a vaccine designed to kill cancer and prevent it from coming back hinges on a high-tech device made by a small company in Oswego County. Roswell Park Cancer Center in Buffalo recently received approval to produce the vaccine, made from human cells, using a […]
Vaccines: Know Your Enemy
By Michael Eisenstein Cancer operates like a well-disguised saboteur. Occasionally it slips up by displaying unusual proteins, tripping immunological surveillance systems that are checking for abnormal growth. For decades now, scientists have tried to exploit this vulnerability with therapeutic vaccines — injections of tumour-associated proteins that essentially hang a ‘Wanted’ poster, helping immune cells recognize […]
Cancer Vaccines Poised to Reach $3 Billion in Sales by 2015
FALLS CHURCH, Va., April 19, 2011 /PRNewswire/ — Technology Catalysts International (TCI), leading global consultants to the pharmaceutical industry, announced that research on cancer trends and development has identified cancer vaccines as a viable treatment option for a variety of cancers that currently have ineffective treatments. The potential of the cancer vaccine market is forecast […]
